Current Drug Metabolism
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 2
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
Li P. Albert, Meet Our Editorial Board Member, Current Drug Metabolism 2016; 17 (2) . https://dx.doi.org/10.2174/138920021702160114150829
DOI https://dx.doi.org/10.2174/138920021702160114150829 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Tissue Distribution and Metabolism of Micro- and Nanoparticles and Medical Implants
With the continuous advancement of modern science and engineering, numerous functional materials and active molecules have been developed and utilized in various industrial, medical, and food applications. Many of these can enter the body, either actively or passively, and have significant and intricate impacts on human health. For example, biomaterials ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Liposomes and Pseudovirions with Fusion Activity for Efficient Gene Delivery
Current Gene Therapy Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy
Current Drug Targets Landscape Analysis of Quercetin: A Potential Candidate Against SARSCoV- 2
Coronaviruses Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine Targets for Medical Therapy to Limit Abdominal Aortic Aneurysm Progression
Current Drug Targets Association of High-Mobility Group Box-1 with Inflammationrelated Cytokines in the Aqueous Humor with Acute Primary Angle-Closure Eyes
Current Molecular Medicine The Adipocyte as a Novel TSH Target
Mini-Reviews in Medicinal Chemistry Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets Using Literature-based Discovery to Identify Novel Therapeutic Approaches
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds
Anti-Cancer Agents in Medicinal Chemistry Controversies in the Use of Nutritional Supplements in Ophthalmology
Current Pharmaceutical Design Triplet Excited States as a Source of Relevant (Bio)Chemical Information
Current Topics in Medicinal Chemistry Microarray-Based Gene Expression Analysis of Hepatocellular Carcinoma
Current Genomics Immunological Approaches for HIV Therapy
Current Drug Targets - Infectious Disorders The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science Acetylenic Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Current Drug Therapy STAT3: A Molecular Target for Cancer Whose Time Has Come
Current Signal Transduction Therapy Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry Insights on Biology and Pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-Catenin, and NF-κB Pathways in Osteoarthritis
Current Pharmaceutical Design